公开(公告)号：US20180060481A1

公开(公告)日：2018-03-01

申请号：US15691683

申请日：2017-08-30

Applicant: Life Technologies Corporation

Inventor： Michael BEVILACQUA ,  Danute Bankaitis-Davis ,  John Cheronis ,  Victor Tryon

IPC: G06F19/18 ,  G06F19/00 ,  G06F19/20 ,  A61B5/0205 ,  A61B5/145 ,  C12Q1/68 ,  G01N33/50 ,  G01N33/574 ,  G01N33/68 ,  A61B5/021 ,  A61B5/024 ,  A61B5/01 ,  C12Q1/70

CPC classification number: G16B20/00 ,  A61B5/01 ,  A61B5/02055 ,  A61B5/021 ,  A61B5/024 ,  A61B5/145 ,  C12Q1/6851 ,  C12Q1/689 ,  C12Q1/6893 ,  C12Q1/6895 ,  C12Q1/701 ,  C12Q2600/158 ,  G01N33/5088 ,  G01N33/57415 ,  G01N33/6803 ,  G01N33/6863 ,  G01N33/6869 ,  G01N33/6893 ,  G01N2800/042 ,  G16B25/00 ,  G16H50/20 ,  Y02A90/26

Abstract: A method is provided in various embodiments for determining a profile data set for a subject with infectious disease or inflammatory conditions related to infectious disease based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 2 constituents from Table 1. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.